STARLIX

This brand name is authorized in Austria, Cyprus, Estonia, Ireland, Lithuania, Poland, Romania, Singapore, United States, South Africa

Active ingredients

The drug STARLIX contains one active pharmaceutical ingredient (API):

1 Nateglinide UNII 41X3PWK4O2 - NATEGLINIDE

Nateglinide is an amino acid (phenylalanine) derivative, which is chemically and pharmacologically distinct from other antidiabetic agents. Nateglinide is a rapid, short-acting oral insulin secretagogue. Its effect is dependent on functioning beta cells in the pancreas islets. Read about Nateglinide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
STARLIX Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BX03	Nateglinide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1013892, 1013904, 1013915, 1080896, 1080908, 1080919, 1080920, 1080931, 1080942, 1092697, 1092709, 1092710, 1092721, 1092732, 1092743, 1092754, 1092765, 1092776, 1092787, 1092798, 1092800
Country: IE	Health Products Regulatory Authority	Identifier(s): 45428
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008568, 1010504, 1030866, 1030867, 1030868, 1030869, 1030870, 1030871, 1030872, 1030873, 1030874, 1030875, 1030876, 1030877, 1030878, 1030879, 1030880, 1030881, 1030882, 1030883, 1030884
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100104357, 100104363, 100104370
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51732001, W51732002, W51732003, W51732004, W51732005, W51732006, W51732007, W51733001, W51733002, W51733003, W51733004, W51733005, W51733006, W51733007, W51758001, W51758002, W51758003, W51758004, W51758005, W51758006, W51758007
Country: SG	Health Sciences Authority	Identifier(s): 11445P, 11448P
Country: US	FDA, National Drug Code	Identifier(s): 0078-0351, 0078-0352
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/21.2/0039, 35/21.2/0040